CHA AI Healthkare Reports Q1 Operating Loss of 2.37 Billion Won
Consolidated Q1 revenue 1.94bn won (up from 1.75bn), operating loss 2.37bn (vs 2.14bn loss), net loss 4.63bn (vs 2.36bn loss).
Accumulated deficit 147.6bn won, debt ratio 53.0% (up from 46.2% at year-end 2025).
Credit rating maintained at BB- (Kretap), same as prior periods.
Major shareholder MetaX1hojo holds 71.23%.
Outstanding convertible bond (40bn won face, conversion price 8,292 won) with derivative liability of 2.85bn won; recognized derivative loss of 2.54bn in Q1.
Equity method loss from Kakao Healthcare of 3.02bn won.
Litigation: 2 cases as plaintiff (~2.25bn won) and 1 case as defendant (~7.75bn won) pending.